281-296-7300

  • Awards
  • Careers
logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • Resource Center
    • News
    • Events
    • FAQs
    • Whitepapers
    • Posters & Presentations
  • Contact Us
  • Awards
  • Careers

News

VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility

October 10, 2022

With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract manufacturer VGXI, Inc. celebrated the official Grand Opening of its new headquarters and expanded manufacturing facility in Conroe, TX. VGXI, Inc., a specialized contract developer and manufacturer (CDMO) of nucleic acid biopharmaceuticals including gene therapies, DNA vaccines, and RNA medicines, celebrated the… Read More »

Filed Under: Events, News

VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility

August 17, 2022

Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening celebration of its new headquarters and expanded manufacturing facility in Conroe, TX. VGXI, Inc., an industry-leading contract developer and manufacturer (CDMO) of nucleic acid biopharmaceuticals including gene therapies, DNA vaccines, and RNA medicines, announces the official Grand Opening celebration for its new… Read More »

Filed Under: Events, News

VGXI Celebrates First Look Event at New Manufacturing Facility

April 18, 2022

VGXI opened the doors of its new headquarters and manufacturing facility on 09Apr22 to provide friends and employee families a first look inside and outside the new site! As production is nearing completion, the event was an opportunity for employees and their families to tour the production suites, labs, and office spaces before the official… Read More »

Filed Under: News

VGXI Official COVID-19 Statement

March 31, 2022

To our Valued Clients and Business Partners, VGXI’s top priority is to continue delivering the highest quality DNA products and services while ensuring the security and safety of our team. VGXI is actively monitoring the evolving situation and will continue to provide updates as new information becomes available. Manufacturing activities have been maintained throughout the… Read More »

Filed Under: Blog, Events, Media, News, Sticky Post

VGXI New Manufacturing Facility Achieves Construction Milestones In Advance of 2022 Operational Date

October 4, 2021

Specialized GMP contract manufacturer VGXI, Inc. announced multiple construction milestones have been reached for its new headquarters and expanded manufacturing facility in Conroe, TX. The Woodlands, TX – VGXI, Inc., an industry leading contract developer and manufacturer (CDMO) for nucleic acid biopharmaceuticals including DNA vaccines and gene therapies, announced that its new headquarters and manufacturing… Read More »

Filed Under: News

VGXI, Inc. Partners with Rare Trait Hope Fund in Support of Gene Therapy for Rare Disease, AGU

August 10, 2021

Industry leading plasmid DNA Manufacturer VGXI, Inc. partners with Rare Trait Hope Fund in support of a gene therapy for the rare genetic disease, Aspartylglucosaminuria (AGU). The Woodlands, TX – Contract developer and manufacturer VGXI, Inc., which specializes in production of nucleic acid-based biopharmaceuticals for DNA vaccines and gene therapy applications, announced it has been… Read More »

Filed Under: General, News

VGXI Celebrates Topping Out for New Headquarters and Manufacturing Facility in Conroe, TX

April 20, 2021

Texas-based plasmid DNA Manufacturer VGXI, Inc. Celebrates the Topping Out for its New Headquarters and Expanded Manufacturing Facility. The Woodlands, TX – VGXI, Inc., a highly specialized contract developer and manufacturer for DNA-based biopharmaceuticals, celebrated a significant milestone for its new headquarters and manufacturing facility with a topping out ceremony on Monday, April 19, 2021…. Read More »

Filed Under: Events, News

VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies

March 16, 2021

Texas-based GMP Plasmid CDMO VGXI, Inc. and Geneos Therapeutics, Inc. Expand their Clinical Manufacturing Supply Agreement in Support of Geneos’ Ongoing GT-30 Phase Ib/IIa Clinical Trial for advanced hepatocellular carcinoma (HCC). The Woodlands, TX – VGXI, Inc., an industry leading manufacturer for pre-clinical through cGMP clinical plasmid DNA, announced that its partner Geneos Therapeutics, Inc…. Read More »

Filed Under: General, News

VGXI Official Update Following Winter Storm Uri

February 23, 2021

To our Valued Clients and Business Partners, Thank you for everyone’s concern regarding the severe winter storm conditions that swept through Texas during the week of 15Feb21. The VGXI offices remained closed for the week to ensure the safety of all our team members as they faced challenges from icy road conditions, power outages, and… Read More »

Filed Under: General, News

VGXI Breaks Ground for New Manufacturing Facility in Conroe, TX

November 10, 2020

Plasmid DNA Manufacturer VGXI, Inc. Breaks Ground for New Conroe-based Manufacturing Facility. The Woodlands, TX – VGXI, a highly regarded CDMO supporting the gene therapy and DNA vaccine industries, held a groundbreaking ceremony on November 10, 2020 for its new greenfield manufacturing facility. The milestone event was hosted by VGXI in accordance with CDC COVID-19… Read More »

Filed Under: News

VGXI Wins Best Contract Manufacturing Organization for the 2020 Vaccine Industry Excellence Awards

October 1, 2020

Texas-based plasmid DNA CDMO VGXI, Inc. was recognized as the winner of the 2020 ViE Award for Best Contract Manufacturing Organization at the World Vaccine Congress Washington. The Woodlands, TX – VGXI, Inc., a contract development and manufacturing organization specialized in production of pre-clinical through cGMP grade DNA-based biopharmaceuticals, announced it has been recognized as… Read More »

Filed Under: General, Media, News

VGXI Completes Land Purchase and Advances Design Development for New Manufacturing Facility

August 6, 2020

Plasmid DNA Manufacturer VGXI, Inc. Completes Land Purchase and Proceeds with Design Development Phase for New Expanded Manufacturing Facility. The Woodlands, TX – VGXI, a highly regarded CDMO supporting the gene therapy and DNA vaccine industries, announces it has closed on the purchase of greenfield for a new, expanded manufacturing facility. The site is located… Read More »

Filed Under: Events, General, News

  • 1
  • 2
  • 3
  • …
  • 7
  • »

Archives

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • About
  • Services
  • VGXI Process
  • Contact Us
  • Careers
  • Awards
  • Resource Center
logo white

281-296-7300
2700 Research Forest Drive, Suite 180
The Woodlands, Texas 77381, USA

Teko Font
Please enter your name.
Please enter a valid email address.
Sign Up

Thanks for subscribing! Please check your email for further instructions.

Something went wrong. Please check your entries and try again.

© 2021 VGXI, Inc. All Rights Reserved.Terms | Privacy Policy